We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Benjamin
Lond
blond@brookes.ac.uk
Dr
Catherine
Henshall
chenshall@brookes.ac.uk
Malignant neoplasms of respiratory and intrathoracic organs
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
There are ~85,000 lung cancer patients (LCPs) in the UK; yet only around 8% were recruited into clinical trials in 2021/22. LCPs need opportunities to take part in clinical trials to access new treatments, increasing their quality of life, treatment choices and life expectancy.
Discussions with nurses can help patients make better treatment decisions, improving experiences of care. However, research has shown that lung cancer nurses (LCNs) often feel unable to discuss participation in trials with patients due to lack of knowledge, confidence, time and training.
This study aims to develop and test a research recruitment tool for LCNs, to support LCPs to enter clinical trials. Objectives include to:
• Explore reasons for low uptake of LCPs into clinical trials
• Develop a tool for LCNs to talk to patients about clinical trials
• Test whether the tool improves the number and quality of discussions nurses have with LCPs about clinical trials
The study has four phases:
Phase 1: A literature review will identify problems that make clinical trial uptake difficult for LCPs, carers and clinicians
Phase 2: Six group discussions with LCNs, patients and carers will explore issues that create potential barriers for patients taking part in clinical trials. The groups will take place online, last approximately one hour and be recorded.
Phase 3: Part 1&2 findings will help us develop a LCN research recruitment tool. The tool will contain information on how nurses obtain information about LC clinical trials, research teams, communication issues, practical issues and how to reach LCPs.
Phase 4: The research recruitment tool will be tested in four UK NHS hospitals. A survey will identify any changes in nurses’ clinical trials awareness and confidence before and after using the tool. Interviews with LCNs, patients and carers will explore their views on the tool, clinical trials participation and experiences of care.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Interventional type: Education or Self-Management;Management of Care;
You can take part if:
You may not be able to take part if:
Focus Groups (Healthcare staff): Exclusion criteria: • Not actively involved in frontline clinical care • Not involved in caring for lung cancer patients for at least 30% of their role Focus groups (patients/carers): Exclusion criteria: • Mesothelioma diagnosis or caring for someone with a mesothelioma diagnosis • Unable to provide informed consent Pilot study and interviews (nurses): Exclusion criteria: • Not actively involved in frontline clinical care • Not involved in caring for lung cancer patients for at least 30% of their role • Employed as a lung cancer research delivery nurse Interviews (patients/carers): Exclusion criteria: • Mesothelioma diagnosis or caring for someone with a mesothelioma diagnosis • Unable to provide informed consent
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
The study is sponsored by Oxford Brookes University and funded by ROY CASTLE LUNG CANCER FOUNDATION .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 56041
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
